Pre-arrest doxycycline protects donation after circulatory death kidneys

Area of Science:

• Transplantation
• Nephrology
• Organ Preservation

Background:

• Donation after circulatory determination of death (DCDD) involves warm ischemic (WI) and cold ischemic (CI) kidney injury.
• Matrix metalloproteinases (MMPs) contribute to CI injury.
• Doxycycline (Doxy), an MMP inhibitor, previously protected kidneys during CI.

Purpose of the Study:

• To investigate if Doxy administered before asystole can prevent WI injury in DCDD kidneys.
• To evaluate Doxy's protective effects against both WI and CI in a DCDD rat model.

Main Methods:

• A rat DCDD model was used with Control, Preemptive Doxy, and Preemptive and Perfusion Doxy groups.
• Kidneys were assessed for warm ischemic injury before cold preservation (22h at 4°C).
• MMP-2 levels in perfusate, NGAL, LDH, and mitochondrial injury were measured.

Main Results:

• Both Doxy treatment groups showed significantly reduced MMP-2 levels in the perfusate compared to controls.
• Reductions in kidney injury markers NGAL, LDH, and MMP-9 were observed in Doxy-treated groups.
• Electron microscopy revealed significantly less mitochondrial damage in kidneys treated with Doxy.

Conclusions:

• Pre-arrest Doxy administration reduced kidney injury markers and morphological damage in a DCDD rat model.
• Doxycycline demonstrates potential as a simple, safe agent to protect transplant kidneys from both warm and cold ischemic injury.
• Further research may validate Doxy's role in improving DCDD kidney transplant outcomes.